Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05762094

A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021

Conditions: Bacterial Infections

Sex: All

Ages: 18 Years – N/A

Enrollment: 1000

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Location: China

Summary

Patients may benefit from the personalized carbapenem dosing strategy based on pharmacokinetics. The objective of this study is to retrospectively review and analyze the clinical outcomes of patients with different dosing strategy.

Eligibility Criteria

Inclusion Criteria:Age over 18 years Chinese patient: male or female Diagnosed as bacterial infection Treated by carbapenem Serum concentration determined during therapyExclusion Criteria:Duration of carbapenem treatment less than 48 hours Patients renal or liver function not tested before treatment started Using more than two kinds of carbapenem

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05762094). StuddyBuddy aggregates publicly available trial information.